Free Trial

Hims & Hers Health (HIMS) Stock Forecast & Price Target

$19.41
-0.96 (-4.71%)
(As of 07/19/2024 ET)

Hims & Hers Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 16 Wall Street analysts who have issued ratings for Hims & Hers Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 7 have given a hold rating, and 9 have given a buy rating for HIMS.

Consensus Price Target

$19.07
-1.74% Downside
High Forecast$26.00
Average Forecast$19.07
Low Forecast$10.00

According to the 16 analysts' twelve-month price targets for Hims & Hers Health, the average price target is $19.07. The highest price target for HIMS is $26.00, while the lowest price target for HIMS is $10.00. The average price target represents a forecasted downside of -1.74% from the current price of $19.41.

TypeCurrent Forecast
7/21/23 to 7/20/24
1 Month Ago
6/21/23 to 6/20/24
3 Months Ago
4/22/23 to 4/21/24
1 Year Ago
7/21/22 to 7/21/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$19.07$16.43$14.85$12.09
Forecasted Upside-1.74% Downside26.82% Upside26.69% Upside25.78% Upside
Get Hims & Hers Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

HIMS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HIMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Hims & Hers Health Stock vs. The Competition

TypeHims & Hers HealthMedical CompaniesS&P 500
Consensus Rating Score
2.56
2.72
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-1.74% Downside3,363.24% Upside9.98% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/18/2024Truist Financial
1 of 5 stars
 Boost TargetHold ➝ Hold$13.00 ➝ $23.00+2.68%
7/11/2024TD Cowen
4 of 5 stars
 Boost TargetBuy ➝ Buy$15.00 ➝ $25.00+18.04%
7/11/2024Piper Sandler
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$16.00 ➝ $18.00-10.91%
6/27/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$14.00 ➝ $23.00+19.98%
6/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$22.00 ➝ $26.00+10.26%
5/22/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$20.00 ➝ $24.00+43.54%
5/22/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$16.00 ➝ $20.00+13.96%
5/7/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$14.00 ➝ $16.00+28.31%
4/26/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Kessler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
2/28/2024Imperial Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$16.00+19.23%
2/27/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$15.00 ➝ $17.00+22.83%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$10.00+5.04%
1/5/2024Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$14.00 ➝ $15.00+81.38%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$14.00+77.22%
4/11/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$10.00+2.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:19 AM ET.

HIMS Forecast - Frequently Asked Questions

What is Hims & Hers Health's forecast for 2024?

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Hims & Hers Health is $19.07, with a high forecast of $26.00 and a low forecast of $10.00.

Should I buy or sell Hims & Hers Health stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. There are currently 7 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HIMS shares.

Does Hims & Hers Health's stock price have much upside?

According to analysts, Hims & Hers Health's stock has a predicted upside of 20.94% based on their 12-month stock forecasts.

Has Hims & Hers Health been downgraded by Wall Street analysts recently?

Over the previous 90 days, Hims & Hers Health's stock had 1 downgrade by analysts.

What analysts cover Hims & Hers Health?
Do Wall Street analysts like Hims & Hers Health more than its competitors?

Analysts like Hims & Hers Health less than other "medical" companies. The consensus rating score for Hims & Hers Health is 2.56 while the average consensus rating score for "medical" companies is 2.72. Learn more on how HIMS compares to other companies.


This page (NYSE:HIMS) was last updated on 7/20/2024 by MarketBeat.com Staff

From Our Partners